Advertisement

Topics

The Medicines Company to Webcast Presentation of ORION-1 Phase II Study of Inclisiran at ACC.17

07:00 EDT 14 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Late-breaking session featuring data from ORION-1 study to be webcast simultaneously with presentation at 1:30 p.m. on March 17, 2017 New Time for Conference Call – Previously-scheduled conference call/webcast to rev...

Other Sources for this Article

Media
Meg Langan, 973-290-6319
Vice President
margaret.langan@themedco.com
or
Investor Relations
Krishna Gorti, M.D., 973-290-6122
Vice President, Investor Relations
krishna.gorti@themedco.com

NEXT ARTICLE

More From BioPortfolio on "The Medicines Company to Webcast Presentation of ORION-1 Phase II Study of Inclisiran at ACC.17"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Clinical Research Organization
Contract Research Organization (CRO) provide research services outsourced on a contract basis to the pharmaceutical, biotechnology, healthcare and medical device industries: biopharmaceutical development biologic assay development commercial...

Cardiology
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...